Next Article in Journal
Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD)
Previous Article in Journal
Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation
 
 
Article

Article Versions Notes

Curr. Oncol. 2021, 28(6), 5054-5066; https://doi.org/10.3390/curroncol28060425
Action Date Notes Link
article xml file uploaded 2 December 2021 06:49 CET Original file -
article xml uploaded. 2 December 2021 06:49 CET Update -
article pdf uploaded. 2 December 2021 06:49 CET Version of Record -
article xml file uploaded 2 December 2021 06:50 CET Update -
article xml uploaded. 2 December 2021 06:50 CET Update -
article pdf uploaded. 2 December 2021 06:50 CET Updated version of record -
article html file updated 2 December 2021 06:51 CET Original file -
article xml file uploaded 2 December 2021 06:51 CET Update -
article xml uploaded. 2 December 2021 06:51 CET Update -
article pdf uploaded. 2 December 2021 06:51 CET Updated version of record -
article xml file uploaded 2 December 2021 06:51 CET Update -
article xml uploaded. 2 December 2021 06:51 CET Update https://www.mdpi.com/1718-7729/28/6/425/xml
article pdf uploaded. 2 December 2021 06:51 CET Updated version of record https://www.mdpi.com/1718-7729/28/6/425/pdf
article html file updated 2 December 2021 06:53 CET Update -
article html file updated 2 December 2021 06:53 CET Update -
article html file updated 30 July 2022 20:02 CEST Update https://www.mdpi.com/1718-7729/28/6/425/html
Back to TopTop